Wells Fargo Maintains Axogen at Overweight, Raises Target to $56
Wells Fargo maintained its Overweight rating and raised its Axogen price target to $56 from $48.
Story updates
02:17:39 PM UTC
SquawkNews
Axogen Is Maintained at Overweight by Wells Fargo